Aptevo Therapeutics Gross Profit 2014-2022 | APVO

Aptevo Therapeutics gross profit from 2014 to 2022. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Aptevo Therapeutics Annual Gross Profit
(Millions of US $)
2021 $12
2020 $4
2019 $
2018 $12
2017 $10
2016 $-2
2015 $17
2014 $29
2013 $
Aptevo Therapeutics Quarterly Gross Profit
(Millions of US $)
2022-03-31 $3
2021-12-31 $4
2021-09-30 $3
2021-06-30 $3
2021-03-31 $2
2020-12-31 $2
2020-09-30 $1
2020-06-30 $0
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31 $2
2018-09-30 $3
2018-06-30 $4
2018-03-31 $2
2017-12-31 $1
2017-09-30 $4
2017-06-30 $1
2017-03-31 $4
2016-12-31 $-9
2016-09-30 $-1
2016-06-30 $4
2016-03-31 $5
2015-12-31
2015-09-30 $3
2015-06-30 $3
2014-12-31
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.018B $0.012B
Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $163.938B 9.97
Bio-Rad Laboratories (BIO.B) United States $14.121B 30.63
QIAGEN (QGEN) Netherlands $10.718B 16.92
Biohaven Pharmaceutical Holding (BHVN) United States $10.276B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.228B 0.00
Arcus Biosciences (RCUS) United States $1.817B 46.07
Emergent Biosolutions (EBS) United States $1.560B 6.68
Myovant Sciences (MYOV) United Kingdom $1.185B 0.00
Zymeworks (ZYME) Canada $0.306B 0.00
Gelesis Holdings (GLS) United States $0.112B 0.00
Ambrx Biopharma (AMAM) United States $0.102B 0.00
Enzo Biochem (ENZ) United States $0.101B 0.00
SQZ Biotechnologies (SQZ) United States $0.090B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00